Spots Global Cancer Trial Database for squamous cell carcinoma of the skin
Every month we try and update this database with for squamous cell carcinoma of the skin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Photodynamic Therapy in Treating Patients With Skin Cancer | NCT00002975 | Non-melanomatou... Precancerous Co... | aminolevulinic ... | - | Roswell Park Cancer Institute | |
| Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of Skin | NCT05886140 | Squamous Cell C... | Carrilizumab wi... | 18 Years - 99 Years | Henan Cancer Hospital | |
| Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC | NCT03291002 | Melanoma (Skin) Squamous Cell C... Carcinoma, Squa... Carcinoma, Aden... | CV8102 CV8102 + anti-P... | 18 Years - | CureVac | |
| Immune System Modulation and Outcome in High-risk cSCC Treated With Surgery and Radiotherapy | NCT05246228 | Squamous Cell C... | Peripheral bloo... | 18 Years - | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | |
| Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions | NCT00391300 | Melanoma (Skin) Non-melanomatou... | bioelectric fie... biopsy histopathologic... | 18 Years - | National Cancer Institute (NCI) | |
| Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer | NCT00423397 | Non-melanomatou... | PEG-interferon ... gefitinib | 18 Years - | National Cancer Institute (NCI) | |
| ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin | NCT00054691 | Skin Cancer | Iressa | 18 Years - | M.D. Anderson Cancer Center | |
| Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin | NCT04204837 | Squamous Cell C... | Nivolumab Nivolumab plus ... | 18 Years - | Salzburger Landeskliniken | |
| Green Tea Extract in Treating Patients With Actinic Keratosis | NCT00005097 | Non-melanomatou... | Polyphenon E an... | 18 Years - | University of California, Irvine | |
| Celecoxib in Preventing Skin Cancer | NCT00025051 | Non-melanomatou... | celecoxib anti-cytokine t... antiangiogenesi... biological ther... cancer preventi... chemoprevention... growth factor a... | 20 Years - 60 Years | National Cancer Institute (NCI) | |
| Radiation Therapy in Treating Patients With Head and Neck Cancer | NCT00021125 | Head and Neck C... Non-melanomatou... | adjuvant therap... radiation thera... | - | National Cancer Institute (NCI) | |
| Green Tea Extract in Treating Patients With Actinic Keratosis | NCT00005097 | Non-melanomatou... | Polyphenon E an... | 18 Years - | University of California, Irvine | |
| Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer | NCT02324608 | Recurrent Skin ... Squamous Cell C... | cetuximab laboratory biom... | 18 Years - | Rutgers, The State University of New Jersey | |
| Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region | NCT05482880 | Cutaneous Squam... Cutaneous Squam... Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... Skin Cancer High-Risk Cance... Quality of Life Satisfaction, P... | Regular care wi... | 18 Years - | Maastricht University Medical Center | |
| Investigation of Desmoplastic Squamous Cell Carcinoma | NCT02717936 | Squamous Cell C... | Immunohistochem... | 18 Years - | University Hospital Tuebingen | |
| Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin | NCT01059305 | Skin Cancer | Erlotinib | 18 Years - | M.D. Anderson Cancer Center | |
| Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer | NCT00663910 | Non-melanomatou... | Aminolevulinic ... biopsy diagnostic imag... therapeutic con... | 18 Years - 120 Years | The Cleveland Clinic | |
| CivaDerm(TM) Surface Therapy Pilot Study | NCT04480645 | Basal Cell Carc... Squamous Cell C... | CivaDerm | 18 Years - | CivaTech Oncology | |
| Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer | NCT00644384 | Non-melanomatou... | acitretin gene expression... northern blotti... polymerase chai... protein express... laboratory biom... | 18 Years - | Mayo Clinic | |
| Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy | NCT04892849 | HNSCC NSCLC Esophageal Canc... Urothelial Carc... Renal Cell Carc... Squamous Cell C... Small Cell Bron... | Conventional Th... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy | NCT04892849 | HNSCC NSCLC Esophageal Canc... Urothelial Carc... Renal Cell Carc... Squamous Cell C... Small Cell Bron... | Conventional Th... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Elucid Labs AIDA™ - Labelled Image Acquisition Protocol | NCT03621462 | Melanoma (Skin) Basal Cell Carc... Squamous Cell C... | Artificial Inte... | 18 Years - | Elucid Labs Inc. | |
| Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of Skin | NCT05886140 | Squamous Cell C... | Carrilizumab wi... | 18 Years - 99 Years | Henan Cancer Hospital | |
| Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin | NCT01823679 | Squamous Cell C... Recurrent Skin ... | Capecitabine | 18 Years - | Stanford University | |
| How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes | NCT03370861 | Autoimmunity Melanoma Merkel Cell Car... Squamous Cell C... Basal Cell Carc... Skin Cancer | Immunotherapy | 18 Years - | Washington University School of Medicine | |
| Preventing Squamous Cell Skin Cancer | NCT02347813 | Squamous Cell C... | Pioglitazone | 18 Years - | University of Rochester | |
| Preventing Squamous Cell Skin Cancer | NCT02347813 | Squamous Cell C... | Pioglitazone | 18 Years - | University of Rochester | |
| Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation | NCT00003611 | Non-melanomatou... | acitretin placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Radiation Therapy in Treating Patients With Head and Neck Cancer | NCT00021125 | Head and Neck C... Non-melanomatou... | adjuvant therap... radiation thera... | - | National Cancer Institute (NCI) | |
| CivaDerm(TM) Surface Therapy Pilot Study | NCT04480645 | Basal Cell Carc... Squamous Cell C... | CivaDerm | 18 Years - | CivaTech Oncology | |
| Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region | NCT05482880 | Cutaneous Squam... Cutaneous Squam... Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... Skin Cancer High-Risk Cance... Quality of Life Satisfaction, P... | Regular care wi... | 18 Years - | Maastricht University Medical Center | |
| T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant | NCT00089180 | Actinic Keratos... Basal Cell Carc... Recurrent Skin ... Squamous Cell C... | liposomal T4N5 ... placebo laboratory biom... | 19 Years - | National Cancer Institute (NCI) | |
| Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region | NCT05482880 | Cutaneous Squam... Cutaneous Squam... Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... Skin Cancer High-Risk Cance... Quality of Life Satisfaction, P... | Regular care wi... | 18 Years - | Maastricht University Medical Center | |
| Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | NCT00002506 | Cervical Cancer Esophageal Canc... Head and Neck C... Lung Cancer Non-melanomatou... Penile Cancer | recombinant int... isotretinoin | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Investigation of Desmoplastic Squamous Cell Carcinoma | NCT02717936 | Squamous Cell C... | Immunohistochem... | 18 Years - | University Hospital Tuebingen | |
| SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas | NCT03894618 | Squamous Cell C... Melanoma Non Small Cell ... Urothelial Carc... Gastric Adenoca... Gastroesophagea... Squamous Cell C... Squamous Cell C... Squamous Cell C... Renal Cell Carc... Hodgkin Lymphom... Diffuse Large B... Mismatch Repair... | SL-279252 | 18 Years - | Shattuck Labs, Inc. | |
| Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC) | NCT01984892 | Melanoma Squamous Cell C... Squamous Cell C... Sarcoma of the ... Basal Cell Canc... Breast Cancer | Poly-ICLC | 14 Years - | Icahn School of Medicine at Mount Sinai | |
| The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy | NCT03737721 | Squamous Cell C... | Avelumab and Ra... | 18 Years - | AHS Cancer Control Alberta | |
| Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | NCT00002506 | Cervical Cancer Esophageal Canc... Head and Neck C... Lung Cancer Non-melanomatou... Penile Cancer | recombinant int... isotretinoin | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Celecoxib in Preventing Skin Cancer | NCT00025051 | Non-melanomatou... | celecoxib anti-cytokine t... antiangiogenesi... biological ther... cancer preventi... chemoprevention... growth factor a... | 20 Years - 60 Years | National Cancer Institute (NCI) | |
| Investigation of a Behavioral Substitute for Sunbathing | NCT00403377 | Melanoma (Skin) Skin Cancer | Intervention | 18 Years - 120 Years | University of Massachusetts, Worcester | |
| Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia | NCT00563290 | Recurrent Skin ... Squamous Cell C... Stage 0 Chronic... Stage I Chronic... | dasatinib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer | NCT00003097 | Non-Melanomatou... | preventative di... | 15 Years - | National Cancer Institute (NCI) | |
| SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck | NCT00006361 | Carcinoma of Un... Head and Neck C... Non-melanomatou... | semaxanib | 18 Years - | National Cancer Institute (NCI) | |
| Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia | NCT00563290 | Recurrent Skin ... Squamous Cell C... Stage 0 Chronic... Stage I Chronic... | dasatinib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma | NCT02507076 | Basal Cell Carc... Eccrine Carcino... Recurrent Adult... Recurrent Melan... Recurrent Skin ... Squamous Cell C... Stage III Adult... Stage IIIB Mela... Stage IIIC Mela... Stage IV Adult ... Stage IV Melano... | isolated limb p... melphalan quality-of-life... | 18 Years - | Albert Einstein College of Medicine | |
| Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of Skin | NCT05886140 | Squamous Cell C... | Carrilizumab wi... | 18 Years - 99 Years | Henan Cancer Hospital | |
| Immune System Modulation and Outcome in High-risk cSCC Treated With Surgery and Radiotherapy | NCT05246228 | Squamous Cell C... | Peripheral bloo... | 18 Years - | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | |
| Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma | NCT05490485 | Squamous Cell C... | Camrelizumab | 18 Years - 99 Years | Henan Cancer Hospital | |
| Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN) | NCT01465815 | Recurrent Skin ... Recurrent Squam... Squamous Cell C... Stage III Squam... Stage IVA Squam... Stage IVB Squam... | erlotinib hydro... linsitinib placebo radiation thera... therapeutic con... laboratory biom... | 18 Years - | OHSU Knight Cancer Institute | |
| Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology | NCT06327971 | Squamous Cell C... | 18 Years - | Queen Mary University of London | ||
| Photodynamic Therapy in Treating Patients With Skin Cancer | NCT00002975 | Non-melanomatou... Precancerous Co... | aminolevulinic ... | - | Roswell Park Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
